Multicancer Early Detection Feasible for Outpatients

WEDNESDAY, Sept. 14, 2022 -- A blood-based multicancer early detection (MCED) test using cell-free DNA (cfDNA) is feasible for outpatients and has a positive predictive value of about 40 percent, according to a study presented at the annual meeting...